|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.000 EUR | +3.45% |
|
+14.50% | -14.29% |
| 06-16 | Clinuvel Pharmaceuticals Advances US Listing Plan With SEC Filing for Nasdaq ADS Upgrade | MT |
| 04-28 | Clinuvel Pharmaceuticals plans level II ADR upgrade and Nasdaq listing as CUVL | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.33% | -0.36% | -3.23% | -17.29% | -20.98% | +18.76% | -22.11% | +13.39% | +72.20% | 62.05B | |
| +0.20% | -9.17% | +6.30% | -0.91% | +4.65% | +58.39% | +196.56% | +193.14% | +292.61% | 54.52B | |
| -3.92% | +37.40% | +37.40% | +37.40% | +37.40% | +37.40% | +37.40% | +37.40% | - | 41.55B | |
| +7.62% | +8.19% | +17.86% | -13.59% | -32.63% | -51.27% | -59.11% | -61.93% | +6.92% | 39.06B | |
| -1.05% | -1.73% | +3.16% | +7.18% | +11.70% | +55.35% | -33.92% | -49.39% | -17.48% | 29.02B | |
| +3.50% | +28.15% | +39.90% | +22.13% | +116.89% | +151.81% | -50.31% | -67.89% | - | 25.38B | |
| -0.78% | -9.50% | +2.74% | +5.67% | -0.56% | +43.87% | +55.34% | +16.98% | +27.38% | 19.62B | |
| +1.74% | -0.39% | -4.81% | -6.96% | -0.13% | -2.93% | +113.90% | -12.02% | - | 16.89B | |
| -0.05% | +0.23% | +1.34% | +21.47% | +32.27% | +61.48% | +101.93% | +188.56% | +334.55% | 15.89B | |
| -1.66% | -0.79% | +0.41% | -5.42% | -13.36% | +65.68% | +341.51% | +8.05% | - | 12.98B | |
| -0.66% | -1.83% | +10.51% | +57.67% | +37.16% | +143.46% | +194.71% | +271.94% | +3,851.10% | 12.89B | |
| -4.33% | +4.90% | -3.55% | -1.81% | -21.36% | -8.66% | +668.48% | +439.69% | +6,130.60% | 12.37B | |
| -0.60% | -2.25% | +9.80% | -0.62% | -7.98% | -1.00% | -43.20% | -33.22% | -34.78% | 10.57B | |
| +1.87% | +9.46% | +18.67% | +34.91% | +41.18% | +163.50% | +186.61% | +433.02% | - | 10.26B | |
| +1.04% | +0.75% | -0.44% | +2.32% | -14.93% | -9.84% | -22.21% | -61.82% | -51.14% | 6.38B | |
| +5.66% | +14.95% | +76.89% | +95.45% | +176.04% | +143.97% | +378.21% | -21.29% | - | 5.45B | |
| -0.24% | -3.32% | -27.10% | -29.88% | -36.49% | -53.25% | -58.27% | -77.10% | - | 5.33B | |
| +3.53% | +2.44% | -9.61% | -14.27% | -2.27% | +7.81% | +244.48% | +179.22% | - | 5.32B | |
| +1.06% | -2.05% | -15.95% | -28.63% | -32.88% | -22.16% | +119.92% | +47.55% | +118.73% | 5.18B | |
| Average | +0.70% | +2.52% | +8.44% | +8.67% | +14.41% | +42.23% | +123.68% | +76.02% | +975.52% | 20.56B | |
| Weighted average by Cap. | +0.58% | +1.71% | +10.30% | +5.53% | +9.99% | +40.37% | +79.74% | +61.13% | +566.03% |
- Stock Market
- Stocks
- CUV Stock
- UR9 Stock
- Sector Clinuvel Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
